IP Library Granted Patent US 6,890,718
Granted Patent B2
US 6,890,718 · App. 10/099,738 · Granted May 10, 2005

External control reagents for nucleic acid amplification

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,890,718
App. No.
10/099,738
Granted
May 10, 2005
Kind
B2
Abstract

External control reagents for nucleic acid amplification are provided that verify the absence or presence of specific target sequences, and correct primers and probes. A single-stranded, external control polynucleotide is amplified with primers of the same sequence as target primers. Probes with detectable labels and sequences specific for target and external control polynucleotides allow for detection and measurement. The primers and the detectable probe are adjacent or substantially adjacent when hybridized to the external control polynucleotide. Target and control amplicons may be detected by increased fluorescence induced by polymerase-mediated 5′ nuclease cleavage or hybridization of a self-quenching probe complementary to both target and external control polynucleotides. A kit of PCR reagents can be dispensed into vessels for rapid and accurate nucleic acid amplification assay, with real-time or end-point measurements. The amplification control reagents, kits, and methods of the present invention provide positive and negative control tests which can be conducted concurrently with target amplification. Allelic differences at genetic loci can be detected, including single nucleotide polymorphisms (SNP).

Claims (37)

1. A kit of reagents for nucleic acid amplification comprising:

a single-stranded external control polynucleotide, a forward primer, a reverse primer, a polymerase, a detectable probe, and one or more nucleotide 5′-triphosphates;

wherein the forward primer and the detectable probe are separated by 0 to 5 macleotides when hybridized to the external control polynucleotide, or its complement, and the reverse primer and the detectable probe are separated by 0 to 5 nucleotides when hybridized to the external control polynucleotide, or its complement.

2. The kit of claim 1 wherein the forward primer and reverse primer are each 10 to 40 nucleotides in length.

3. The kit of claim 1 wherein the single-stranded external control polynucleotide is 30 to 110 nucleotides in length.

4. The kit of claim 1 wherein the single-stranded external control polynucleotide is 50 to 70 nucleotides in length.

5. The kit of claim 1 wherein the external control polynucleotide, or its complement, forms single-stranded overhangs consisting of 1 to about 10 nucleotides when hybridized to the forward primer or to the reverse primer.

6. The kit of claim 1 wherein said polymerase is a thermostable polymerase with 5′ nuclease activity.

7. The kit of claim 1 wherein the detectable probe comprises a fluorescent dye.

8. The kit of claim 1 wherein the detectable probe is a self-quenching fluorescence probe comprising a reporter dye and a quencher.

9. The kit of claim 8 wherein the self-quenching fluorescence probe is 10 to 40 nucleotides in length.

10. The kit of claim 8 wherein said reporter dye is a xanthene dye.

11. The kit of claim 10 wherein said xanthene dye is a fluorescein dye.

12. The kit of claim 11 wherein said fluorescein dye is selected from the group consisting of:

where X is an attachment site to the probe.

13. The kit of claim 8 wherein said quencher is selected from the group consisting of:

where X is an attachment site to the probe.

14. The kit of claim 8 wherein said reporter dye is separated from said quencher by at least 12 nucleotides.

15. The kit of claim 8 wherein said reporter dye is attached at a 5′ terminus or a 3′ terminus of the self-quenching fluorescence probe.

16. The kit of claim 8 wherein said quencher is attached at a 5′ terminus or a 3′ terminus of the self-quenching fluorescence probe.

17. The kit of claim 8 wherein said quencher is non-fluorescent.

18. The kit of claim 1 wherein the detectable probe is labelled with a minor groove binder.

19. The kit of claim 8 wherein the self-quenching fluorescence probe is labelled with a minor groove binder.

20. The kit of claim 8 wherein the self-quenching fluorescence probe is labelled with a minor groove binder at a 3′ terminus nucleotide.

21. The kit of claim 19 wherein the minor groove binder has the structure:

where X is an attachment site to the probe.

22. The kit of claim 1 where one or more nucleotide 5′-triphosphates comprises a fluorescent dye, a quencher, biotin, or a minor groove binder.

23. The kit of claim 8 further comprising a second self-quenching fluorescence probe comprising a reporter dye and a quencher wherein the sequences of the first self-quenching fluorescence probe and second self-quenching fluorescence probe differ by a single nucleotide.

24. The kit of claim 1 wherein the concentration of the forward primer and the concentration of the reverse primer is each about 10 to 100 μM, the concentration of each nucleotide 5′-triphosphate is about 100 to 1000 μM, and the concentration of the self-quenching fluorescence probe is about 1 to 100 μM.

25. The kit of claim 1 further comprising a second single-stranded external control polynucleotide wherein the forward primer and the detectable probe are separated by 0 to 5 nucleotides when hybridized to the second external control polynucleotide, or its complement, and the reverse primer and the detectable probe are separated by 0 to 5 nucleotides when hybridized to the external control polynucleotide, or its complement; and

wherein the sequence complementary to the detectable probe of the first single-stranded external control polynucleotide differs from the sequence complementary to the detectable probe of the second single-stranded external control polynucleotide by one or more nucleotides, nucleotide insertions, or nucleotide deletions.

26. The kit of claim 1 where the reagents are delivered by robotic means to one or more vessels.

27. The kit of claim 26 where the reagents are spotted on an absorbent or porous material.

28. The kit of claim 26 where the reagents are spotted on a non-absorbent and planar surface.

29. The kit of claim 26 wherein the reagents are located in an array configuration having 6 to 1536 reaction sites.

30. The kit of claim 29 wherein the reagents are located in a microwell tray having 96 to 384 wells.

31. The kit of claim 30 wherein each well has a volume from 1 to 500 μl.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY NAME PREVIOUSLY RECORDED AT REEL: 030182 FRAME: 0677. ASSIGNOR(S) HEREBY CONFIRMS THE RELEASE OF SECURITY INTEREST. Recorded Mar 4, 2016
From: BANK OF AMERICA, N.A.
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 038000/0397 →
LIEN RELEASE Recorded Apr 9, 2013
From: BANK OF AMERICA, N.A.
To: APPLIED BIOSYSTEMS, INC.
Reel/Frame 030182/0677 →
CHANGE OF NAME Recorded Feb 26, 2010
From: APPLERA CORPORATION
To: APPLIED BIOSYSTEMS INC.
Reel/Frame 023994/0538 →
MERGER Recorded Feb 26, 2010
From: APPLIED BIOSYSTEMS INC.
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 023994/0587 →
SECURITY AGREEMENT Recorded Dec 5, 2008
From: APPLIED BIOSYSTEMS, LLC
To: BANK OF AMERICA, N.A, AS COLLATERAL AGENT
Reel/Frame 021976/0001 →